Natural products are reported to be useful for controlling or preventing T2DM as an antiinflammatory, AMPK activators, insulin secretion stimulators, alpha-glucosidase
Introduction
The prevalence of type 2 diabetes parallel to obesity is increasing worldwide 1 . Approximately, 23% of patients with morbid obesity have type 2 diabetes, and the spread of screening-detected diabetes is 8% 2 . T2DM have raising rates in overweight and obesity in adults as well as in youth 3 .Many of oral antidiabetic agents have been developed through the last 40 years 4, 5 . Natural compounds reported to be useful in controlling or preventing T2DM namely as anti-inflammation, AMPK activators, insulin secretion stimulators, alphaglucosidase / disaccharidase or amylase inhibitors, and acting with an unknown mechanism 6 . Evening primrose-Oenothera Historically, evening primrose (Oenothera spp.) has been recognized as a valid health care product 8 . Evening primrose was a fundamental food to improve ailments such as bruising, stomachaches, and shortness of breath 9 . Evening primrose oil is a substantialsource of omega-6 essential fatty acids, mostly gamma-linolenic acid (GLA) and linoleic acid (LA), both major components of myelin and the neuronalcell membrane 10 .
Researchers have found that the high concentrations of GLA found in evening primrose oil can be used to treat several pathological conditions in humans caused by GLA deficiencies, and minimize the severity of many diseases 9 .
Gamma-linolenic acid has anti-inflammatory, antithrombotic, and lipid reducing effect. It also enhances smooth muscle relaxation and vasodilatation. In addition, EFAs including GLA are substantial constituents of membrane phospholipids,including the mitochondrial membrane, where they promote the integrity and fluidity of the membrane 11 . LA forms GLA by Δ-6-desaturase enzyme, and the activity of this enzyme is compromised in patients with T2DM
10
. Lifestyle factors like stress, smoking, over consumption of alcohol, saturated and trans-fatty acids and nutritional deficiencies of VitaminB6, zinc, and magnesium suppress Δ-6-desaturase 12 .
As a result of restrictions in vivo the production of GLA, supplementation with preformed GLA is becoming substantial.
This has led to attention in developmentand commercialization of the sources of GLA 13 . Evening primrose oil may have an ability to reduce body weight by lowering cholesterol level, reduce symptomatic diabetic neuropathy, reduce blood pressure, and also reduce inflammation associated with diabetes 10 .
Due to the lack of studies to evaluate the effect of evening primrose oil in reducing the complications of T2DM, this study was designed to track the efficacy of primrose oil in T2DM in glycemic control and lipid reducing effect, consequently ameliorating complications of T2DM. 
Materials and Methods

Study design
Methods
Serum fasting glucose is measured using Hexokinase/G-6-PDH
14
. The fasting total cholesterol levels has been measured using enzymatic assay, triglycerides were enzymatically measured using Glycerol Phosphate Oxidase, andthe HDL-C 
Statistical analysis
The statistical analyses were carried out using the computer 
Results and Discussions
Patients demographic characteristics
The demographic data of the 40 patients are presented in ±1.6) kg/m2 with and group 2 with. Statistical differences were found between patient groups and control subjects (P< 0.001). In the present study, there were significant elevation in baseline level of fasting serum glucose and HbA1cin both patient groups 1 and 2 compared to control subjects, with statistically high difference were found between patient groups and control subjects (P< 0.001).Also highly significant reduction in FBG after 3 months of treatment was found in both patient groups compared to pre treatment level (P< 0.001), but no significant difference in fasting serum glucose reduction between patient groups ( Table 2) . The addition of evening primrose oil to metformin therapy in newly diagnosed T2DM patients non significantly reduced the fasting serum glucose level compared to patients on metformin alone with same regimen, this is obviously due to the potent pharmacologic effect of metformin on glycemic control. In a preliminary study done by Takahashi Additionally, in the current study, the high level of HbA1c in newly diagnosed T2DM patientsshowed no significant reduction after the addition of evening primrose oil to metformin, and this result is compatible with the previously mentioned study 20 .
Changes in metabolic markers in type 2 diabetic patients
Although Takashige et al found a significant reduction in HbA1c % in patient treated with evening primrose oil after twelve weeks of treatment 24 .
There were significant elevation in a baseline level of total cholesterol and LDL-C inboth patient groups 1 and 2 compared to control subjects, with statistically high difference was found between patient groups and control subjects (P<0.001). The highly significant reduction after 3 months of treatment was found in both patient groups compared to pre treatment level(P< 0.001), but no significant difference in both parameters between patient groups (Table 3) . Both triglyceride and VLDL-C showed no significant difference in baseline levelof in patient groups 1 and 2 compared to control subjects, but highly significant reduction after 3 months of treatment was found in both patient groups compared to pre treatment level (P<0.001), still no significant difference in TG and VLDL-C reduction between patient groups. The level of serum HDL showed lower levels in a baseline in both patient groups 1 and 2 compared to control subjects, significantly in patient groups 2 only (P<0.05).
Also significant increase in serum HDL after 3 months of treatment was found in both patient groups compared to pre treatment level (P< 0.05), again, no significant difference in serum HDL increase between patient groups. The effect of EPO on metabolic parameters in the present study is expected to be underestimated because of the small sample size and the programmed metformin therapy for the newly diagnosed patients.
Changes in insulin resistance and β cell function markers in type 2 diabetic patients
The significantly high baseline level of fasting serum insulin (FSI) was found in both patient groups 1 and 2 compared to control subjects, and highly significant decline in FSI level post treatment was found in group 2 patients only compared to pre treatment level (P< 0.001), but no significant reduction was found in group 1 patients compared to pre treatment level.
Additionally, both insulin resistance (HOMA-IR) and β cell function (HOMA-B) showed statistically significant opposing difference between patient groups and control subjects (P< 0.001), with highly significant elevation in β cell function and decrease in insulin resistance after 3 months of treatment in both patient groups compared to pre treatment level (P< 0.001), and no significant difference between them (Table 4) . The elevation in the level of fasting serum insulin is the major metabolic consequences of hyperglycemia in T2DM patients. 
Conclusion
To our knowledge, we are aware of no randomized controlled trial that assessed the effect EPO administration on metabolic markers in type 2 diabetic patients, particularly among Iraqi population. The significant reduction in FSIlevel after three months of combining evening primrose oil supplement to the conventional metformin therapy, and the non significant improvement in insulin resistance and β cell function give no doubt that GLA played a pivotal role in a disease process, and the dietary control of fatty acid intake would be expected to modify the disease progression. From the results, it can be concluded that early supplementation with natural oil rich in gamma linolenic acid with hypoglycemic drugs can improve therapeutic outcome and slows the progression of diabetes complications.
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